BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Flórez-Álvarez L, Ruiz-Perez L, Taborda N, Hernandez JC. Toll-like receptors as a therapeutic target in cancer, infections and inflammatory diseases. Immunotherapy 2020;12:311-22. [PMID: 32237938 DOI: 10.2217/imt-2019-0096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ashayeri Ahmadabad R, Mirzaasgari Z, Gorji A, Khaleghi Ghadiri M. Toll-Like Receptor Signaling Pathways: Novel Therapeutic Targets for Cerebrovascular Disorders. Int J Mol Sci 2021;22:6153. [PMID: 34200356 DOI: 10.3390/ijms22116153] [Reference Citation Analysis]
2 Li L, Jin J, Liu H, Ma X, Wang D, Song Y, Wang C, Jiang J, Yan G, Qin X, Li L. Notch1 signaling contributes to TLR4-triggered NF-κB activation in macrophages. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153894] [Reference Citation Analysis]
3 Giustarini G, Pavesi A, Adriani G. Nanoparticle-Based Therapies for Turning Cold Tumors Hot: How to Treat an Immunosuppressive Tumor Microenvironment. Front Bioeng Biotechnol 2021;9:689245. [PMID: 34150739 DOI: 10.3389/fbioe.2021.689245] [Reference Citation Analysis]